Neumora Therapeutics, Inc.
NMRA
$1.63
$0.010.62%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -41.45% | -41.01% | -32.25% | -33.02% | 14.63% |
Total Receivables | -- | -- | -- | -- | 174.58% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 39.07% | -5.72% | -70.75% | 292.27% | 232.70% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -91.69% | -80.75% | -91.30% | 98.90% |
Total Current Assets | -44.04% | -42.44% | -34.34% | -33.69% | 18.33% |
|
|||||
Total Current Assets | -44.04% | -42.44% | -34.34% | -33.69% | 18.33% |
Net Property, Plant & Equipment | -87.49% | -68.16% | -57.47% | -50.19% | -43.10% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -75.43% | -- | -- | -- | -74.55% |
Total Assets | -44.66% | -42.97% | -36.12% | -35.28% | 12.37% |
|
|||||
Total Accounts Payable | -40.48% | -29.49% | 881.31% | 173.98% | -86.76% |
Total Accrued Expenses | 10.65% | 34.78% | 15.69% | -2.52% | 26.80% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -95.26% | -73.13% | -45.15% | -19.22% | 8.55% |
Total Finance Division Other Current Liabilities | -33.83% | -8.27% | -4.32% | -10.74% | -15.82% |
Total Other Current Liabilities | -33.83% | -8.27% | -4.32% | -10.74% | -15.82% |
Total Current Liabilities | -8.51% | 15.34% | 19.02% | 9.00% | -11.36% |
|
|||||
Total Current Liabilities | -8.51% | 15.34% | 19.02% | 9.00% | -11.36% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -85.81% | -70.74% | -59.73% |
Total Liabilities | 76.38% | 10.58% | 10.28% | -0.80% | -22.12% |
|
|||||
Common Stock & APIC | 4.47% | 5.22% | 5.26% | 9.15% | 4,088.71% |
Retained Earnings | -30.90% | -34.08% | -34.66% | -49.39% | -50.62% |
Treasury Stock & Other | 91.98% | 97.97% | 181.58% | 133.76% | 58.26% |
Total Common Equity | -52.03% | -46.21% | -38.80% | -37.44% | 174.24% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -52.03% | -46.21% | -38.80% | -37.44% | 174.24% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -52.03% | -46.21% | -38.80% | -37.44% | 15.48% |
|